(Q37323461)

19 August 2017

A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis (English)

1 reference

randomized controlled trial

19 August 2017

0 references

1 reference

2

Michelle D Shardell

1 reference

19 August 2017

1

Samer S El-Kamary

1 reference

19 August 2017

Mohamed Abdel-Hamid

3

1 reference

19 August 2017

Soheir Ismail

4

1 reference

19 August 2017

Mohamed El-Ateek

5

1 reference

19 August 2017

Mohamed Metwally

6

1 reference

19 August 2017

Nabiel Mikhail

7

1 reference

19 August 2017

Mohamed Hashem

8

1 reference

19 August 2017

Amr Mousa

9

1 reference

19 August 2017

Amr Aboul-Fotouh

10

1 reference

19 August 2017

Mohamed El-Kassas

11

1 reference

19 August 2017

Gamal Esmat

12

1 reference

19 August 2017

G Thomas Strickland

13

1 reference

19 August 2017

19 March 2009

1 reference

19 August 2017

1 reference

19 August 2017

16

1 reference

19 August 2017

5

1 reference

19 August 2017

391-400

1 reference

Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733865

Active surveillance for acute viral hepatitis in rural villages in the Nile Delta

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733865

Milk thistle for alcoholic and/or hepatitis B or C liver diseases--a systematic cochrane hepato-biliary group review with meta-analyses of randomized clinical trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733865

Silymarin treatment of viral hepatitis: a systematic review

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733865

Global epidemiology of hepatitis C virus infection

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733865

A review of Silybum marianum (milk thistle) as a treatment for alcoholic liver disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733865

Randomised double-blinded trial evaluating silymarin for chronic hepatitis C in an Egyptian village: study description and 12-month results

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733865

Molecular Structure and Stereochemistry of Silybin A, Silybin B, Isosilybin A, and Isosilybin B, Isolated from Silybum marianum (Milk Thistle)

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733865

Milk thistle for the treatment of liver disease: a systematic review and meta-analysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733865

The use of silymarin in the treatment of liver diseases

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733865

A review of plants used in the treatment of liver disease: part two.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733865

Chemotherapy of Amanita phalloides poisoning with intravenous silibinin

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733865

The treatment of acute infectious hepatitis. Controlled studies of the effects of diet, rest, and physical reconditioning on the acute course of the disease and on the incidence of relapses and residual abnormalities

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733865

Results of a double blind study on the effect of silymarin in the treatment of acute viral hepatitis, carried out at two medical centres (author's transl)

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733865

A divergent genotype of hepatitis E virus in Chinese patients with acute hepatitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733865

Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733865

ELISA for antibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: identification of HEV infection in primates

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733865

Silibinin is a potent antiviral agent in patients with chronic hepatitis C not responding to pegylated interferon/ribavirin therapy.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733865

Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733865

Two-year results of a randomised double-blinded trial evaluating silymarin for chronic hepatitis C.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733865

Optimization, assessment, and proposed use of a direct nested reverse transcription-polymerase chain reaction protocol for the detection of hepatitis C virus.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733865

Acute viral hepatitis in Hanoi, Viet Nam.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733865

Milk thistle: effects on liver disease and cirrhosis and clinical adverse effects

2 September 2018

1 reference

12 December 2020

[The chemistry and analysis of silymarin from Silybum marianum Gaertn]

1 reference

12 December 2020

[Silymarin for the treatment of acute viral hepatitis? Report of a controlled trial (author's transl)]

1 reference

12 December 2020

Silymarin in the treatment of acute viral hepatitis

1 reference

12 December 2020

Protection by silibinin against Amanita phalloides intoxication in beagles

1 reference

12 December 2020

[Immunomodulator effect of silymarin therapy in chronic alcoholic liver diseases]

1 reference

12 December 2020

Prevention by silymarin of membrane alterations in acute CCl4 liver damage

1 reference

12 December 2020

Antioxidant activity of silybin in vivo during long-term iron overload in rats

1 reference

12 December 2020

A review of plants used in the treatment of liver disease: part 1

1 reference

12 December 2020

10.1016/J.PHYMED.2009.02.002

Identifiers

DOI

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

19303273

1 reference